Contract Service Directory

JRS Pharma





Company Headquarters

2981 Route 22
Patterson, NY 12563
United States

Company Description

 
JRS PHARMA is a manufacturer of excipients, offering pharmaceutical and nutraceutical companies a wide range of innovative excipient products that enable scale-up, improve content uniformity and optimize formulations.
 
Our excipients portfolio includes: high functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, carriers, and coatings. In addition to our wide range of excipients, we offer excellent technical and formulation support to address the needs of our customers. Our high-functionality excipients offer unique benefits that are well suited for emerging production processes, such as continuous manufacturing.

Our innovative excipients and coatings, along with our formulation expertise, provide our customers with a complete portfolio of solutions for the development and manufacture of solid and liquid dosage forms.
 
 

Contract Service Directory

    Content From JRS Pharma

    Related Content

    • Breaking News | Excipients | Facilities | Industry News
      JRS Pharma Receives EXCiPACT GMP Certification for the Production of MCC

      JRS Pharma Receives EXCiPACT GMP Certification for the Production of MCC

      The certificate for Changzhou, China facilities helps drug manufacturers reduce efforts and costs.
      Contract Pharma Staff 09.01.20

    • Breaking News | Promotions & Moves
      Agios Pharmaceuticals Appoints CSO

      Agios Pharmaceuticals Appoints CSO

      Dr. Car spent 25 years at Bristol-Myers Squibb and its legacy companies
      12.02.19

    • Drug Development | Drug Discovery


    • Drug Development

    • AAPS Exhibitor List

      ...
      10.29.19




    • Regulatory Affairs
      Continuous Manufacturing and its Regulatory Challenge

      Continuous Manufacturing and its Regulatory Challenge

      ...
      José L. Toro, PhD, Lachman Consultants 09.16.19

    • Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent to scale-up manufacturing of LTX-03 for clinical testing
      09.16.19


    • Ophthalmic Drug Delivery for Retinal Disorders

      Ophthalmic Drug Delivery for Retinal Disorders

      This whitepaper explores the development and manufacturing considerations associated with ophthalmic drug delivery, with a focus on retinal disorders.

    • Tergus Pharma

      Tergus Pharma

      Tergus is a full-service topical pharmaceutical research, development, testing and commercial manufacturing company.
      09.10.19

    • Biologics, Proteins, Vaccines | Drug Delivery | Injectables
      Growth in Biologics and Maintaining Patient Satisfaction

      Growth in Biologics and Maintaining Patient Satisfaction

      Vicki A. Barbur of Battelle discusses the driving forces for biologics, the challenges, and new delivery methods
      Kristin Brooks, Contrct Pharma 08.09.19


    • Trials & Filings
      La Jolla Pharma Receives Orphan Designation for Malaria Treatment

      La Jolla Pharma Receives Orphan Designation for Malaria Treatment

      LJPC-0118, artesunate, demonstrated to be superior to quinine in reducing mortality in patients with falciparum malaria infection
      07.23.19

    • cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
      GSK Opens Two Mfg. Facilities in Singapore

      GSK Opens Two Mfg. Facilities in Singapore

      Invests $95 million for continuous manufacturing to shorten timelines to produce daprodustat
      07.09.19